ArticleJPRAS open2022

Cost-effectiveness of atenolol compared to propranolol as first-line treatment of infantile haemangioma: A pilot study.

Sasha Wilson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.